4.7 Article

Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo

期刊

BLOOD
卷 121, 期 10, 页码 1858-1867

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2012-07-443325

关键词

-

资金

  1. Heart, Lung, and Blood Institute of the National Institutes of Health [HL-44612, P01HL110860]

向作者/读者索取更多资源

The integrin family is composed of a series of 24 alpha beta heterodimer transmembrane adhesion receptors that mediate cell-cell and cell-extracellular matrix interactions. Adaptor molecules bearing immunoreceptor tyrosine-based activation motifs (ITAMs) have recently been shown to cooperate with specific integrins to increase the efficiency of transmitting ligand-binding-induced signals into cells. In human platelets, Fc receptor gamma-chain IIa (Fc gamma RIIa) has been identified as an ITAM-bearing transmembrane receptor responsible for mediating outside-in signaling through alpha IIb beta 3, the major adhesion receptor on the platelet surface. To explore the importance of Fc gamma RIIa in thrombosis and hemostasis, we subjected Fc gamma RIIa-negative and Fc gamma RIIa-positive murine platelets to a number of well-accepted models of platelet function. Compared with their Fc gamma RIIa-negative counterparts, Fc gamma RIIa-positive platelets exhibited increased tyrosine phosphorylation of Syk and phospholipase C gamma 2 and increased spreading upon interaction with immobilized fibrinogen, retracted a fibrin clot faster, and showed markedly enhanced thrombus formation when perfused over a collagen-coated flow chamber under conditions of arterial and venous shear. They also displayed increased thrombus formation and fibrin deposition in in vivo models of vascular injury. Taken together, these data establish Fc gamma RIIa as a physiologically important functional conduit for alpha(IIb)beta(3)-mediated outside-in signaling, and suggest that modulating the activity of this novel integrin/ITAM pair might be effective in controlling thrombosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Hematology

Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen-Bethesda assay for factor VIII inhibitors

C. H. Miller, A. B. Payne, J. Driggers, D. Ellingsen, B. Boylan, C. J. Bean

HAEMOPHILIA (2018)

Article Multidisciplinary Sciences

Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration

Nathalie Cloutier, Isabelle Allaeys, Genevieve Marcoux, Kellie R. Machlus, Benoit Mailhot, Anne Zufferey, Tania Levesque, Yann Becker, Nicolas Tessandier, Imene Melki, Huiying Zhi, Guy Poirier, Matthew T. Rondina, Joseph E. Italiano, Louis Flamand, Steven E. McKenzie, Francine Cote, Bernhard Nieswandt, Waliul I. Khan, Matthew J. Flick, Peter J. Newman, Steve Lacroix, Paul R. Fortin, Eric Boilard

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Hematology

Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia

Claire Kizlik-Masson, Quentin Deveuve, Yuhang Zhou, Caroline Vayne, Gilles Thibault, Steven E. McKenzie, Claire Pouplard, Stephane Loyau, Yves Gruel, Jerome Rollin

Letter Hematology

Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors

Amanda B. Payne, Connie H. Miller, Dorothy Ellingsen, Jennifer Driggers, Brian Boylan, Christopher J. Bean

HAEMOPHILIA (2019)

Article Health Care Sciences & Services

Clinical Transformation in Care for Patients With Sickle Cell Disease at an Urban Academic Medical Center

Sanaa Rizk, David Axelrod, Gaye Riddick-Burden, Elisabeth Congdon-Martin, Steven McKenzie, Carol Haines, Lawrence Ward, John McAna, Albert G. Crawford

AMERICAN JOURNAL OF MEDICAL QUALITY (2020)

Article Hematology

Evaluation of anti-factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents

Brian Boylan, Glenn P. Niemeyer, Bonnie Werner, Connie H. Miller

Summary: This study aimed to evaluate the anti-FVIII antibody response in patients receiving ITI or BPA, showing a higher frequency of anti-FVIII IgG(4) positivity. Analysis of anti-FVIII antibody levels in patients undergoing ITI revealed that antibodies can persist even after the patient's NBA result falls into the negative range.

HAEMOPHILIA (2021)

Editorial Material Hematology

Sugar and spike: not so nice Comment

Steven E. McKenzie

Summary: The study found that COVID-19 infection leads to aberrant glycosylation of anti-spike IgG, resulting in increased prothrombotic platelet activation.
Article Hematology

Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice

Stephanie A. Renna, James Michael, Xianguo Kong, Lin Ma, Peisong Ma, Marvin T. Nieman, Leonard C. Edelstein, Steven E. McKenzie

Summary: The study found functional differences between human and mouse PAR4, including responsiveness and signaling pathways, highlighting the importance of considering these differences when interpreting mouse PAR4 studies.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Platelet protease activated receptor 4 (PAR 4) receptor genotype is associated with an increased risk of preterm birth

Rupsa C. Boelig, Tara J. Cahanap, Lin Ma, Tingting Zhan, Vincenzo Berghella, Joanna S. Y. Chan, Walter K. Kraft, Steven E. Mckenzie

Summary: The PAR4 Thr120 variant of the platelet receptor is associated with an increased risk of placental vascular pathology and preterm birth in homozygous individuals.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Editorial Material Hematology

A vision for a quicker definitive diagnosis of HIT

Steven E. McKenzie

Article Hematology

Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition

Stephanie A. Renna, Xuefei Zhao, Satya P. Kunapuli, Peisong Ma, Michael Holinstat, Matthew B. Boxer, David J. Maloney, James V. Michael, Steven E. Mckenzie

Summary: This study investigated the cooperativity of PARs (protease-activated receptors) and Fc & gamma;RIIA in HIT using human and mouse model systems. It was found that pharmacological inhibition of 12-LOX can decrease platelet procoagulant phenotype and reduce thrombocytopenia and thrombosis in a mouse model of HIT.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

Letter Hematology

Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab

Connie H. Miller, Brian Boylan, Amanda B. Payne, Jennifer Driggers, Christopher J. Bean

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)

Article Hematology

GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets

Xi Chen, Shuchi Gupta, Matthew Cooper, Daniel DeHelian, Xuefei Zhao, Meghna U. Naik, Jeremy G. T. Wurtzel, Timothy J. Stalker, Lawrence E. Goldfinger, Jeffrey Benovic, Lawrence F. Brass, Steven E. McKenzie, Ulhas P. Naik, Peisong Ma

BLOOD ADVANCES (2020)

暂无数据